These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20590421)

  • 1. Essential blepharospasm.
    Coscarelli JM
    Semin Ophthalmol; 2010 May; 25(3):104-8. PubMed ID: 20590421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facial dystonia, essential blepharospasm and hemifacial spasm.
    Holds JB; White GL; Thiese SM; Anderson RL
    Am Fam Physician; 1991 Jun; 43(6):2113-20. PubMed ID: 2042553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin in the treatment of paralytic strabismus and essential blepharospasm.
    Thomas R; Mathai A; Rajeev B; Sen S; Jacob P
    Indian J Ophthalmol; 1993 Oct; 41(3):121-4. PubMed ID: 8125543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontalis suspension for essential blepharospasm unresponsive to botulinum toxin therapy. First results.
    Roggenkämper P; Nüssgens Z
    Ger J Ophthalmol; 1993 Nov; 2(6):426-8. PubMed ID: 8312829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of botulinum toxin in the treatment of essential blepharospasm].
    Safran AB
    Schweiz Rundsch Med Prax; 1990 Nov; 79(48):1512-4. PubMed ID: 2255835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blepharospasm; results of treatment with botulin].
    Aramideh M; Devriese PP; Ongerboer de Visser BW; Brans JW; Speelman JD
    Ned Tijdschr Geneeskd; 1993 Jul; 137(30):1509-12. PubMed ID: 8366939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and therapeutic aspects of essential blepharospasm].
    Russegger L; Grunert V
    Nervenarzt; 1989 Jul; 60(7):401-6. PubMed ID: 2761660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
    Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
    J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Essential blepharospasm: literature review].
    Nicoletti AG; Aoki L; Nahas TR; Matayoshi S
    Arq Bras Oftalmol; 2010; 73(5):469-73. PubMed ID: 21225137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-associated facial dyskinesias--a study of 238 patients.
    Mauriello JA; Carbonaro P; Dhillon S; Leone T; Franklin M
    J Neuroophthalmol; 1998 Jun; 18(2):153-7. PubMed ID: 9621275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of blepharospasm and facial hemispasm by injection of botulinum toxin].
    Saraux H
    J Fr Ophtalmol; 1988; 11(3):237-40. PubMed ID: 3418019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of blepharospasm with botulinum toxin type A.
    Nüssgens Z; Roggenkämper P
    Ger J Ophthalmol; 1995 Nov; 4(6):363-7. PubMed ID: 8751102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical technique for patients with the apractic type of essential blepharospasm: case report.
    Smet H; De Wilde F; Tassignon MJ
    Bull Soc Belge Ophtalmol; 1994; 254():85-8. PubMed ID: 7493130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin therapy of eye muscle disorders. Safety and effectiveness. American Academy of Ophthalmology.
    Ophthalmology; 1989 Sep; Suppl():37-41. PubMed ID: 2779991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum toxin in the treatment of blepharospasm. Initial experience].
    Růzicka E; Roth J; Diblík P
    Cas Lek Cesk; 1992 Apr; 131(7):213-6. PubMed ID: 1638609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term treatment with botulinum toxin: dosage, treatment schedules and costs].
    Schnider P; Birner P; Moraru E; Auff E
    Wien Klin Wochenschr; 1999 Jan; 111(2):59-65. PubMed ID: 10081123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
    Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
    Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blepharospasm and hemifacial spasm treated with botulinum A toxin injection].
    Wang J; Lin S; Zhang X
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Oct; 33(5):291-3. PubMed ID: 11717871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm].
    Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F
    Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid agonists in the treatment of blepharospasm--a case report study.
    Gauter B; Rukwied R; Konrad C
    Neuro Endocrinol Lett; 2004; 25(1-2):45-8. PubMed ID: 15159681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.